References

1. World Health Organization Obesity and Overweight. Available online: (accessed on 21 November 2020).
2. O’Rourke, R.W. The Pathophysiology of Obesity and Obesity-Related Disease. In The ASMBS Textbook of Bariatric Surgery; Nguyen, N., Brethauer, S., Morton, J., Ponce, J., Rosenthal, R., Eds.; Springer: Cham, Switzerland, 2020; pp. 15–36.
3. Skinner, A.C.; Perrin, E.M.; Moss, L.A.; Skelton, J.A. Cardiometabolic risks and severity of obesity in children and young adults. N. Engl. J. Med. 2015, 373, 1307–1317.
4. Mitsis, T.; Pierouli, K.; Diakou, K.I.; Papakonstantinou, E.; Bacopoulou, F.; Chrousos, G.P.; Vlachakis, D. Exosomics. EMB Net. J. 2020, 26, e934.
5. Raposo, G.; Stahl, P.D. Extracellular vesicles: A new communication paradigm? Nat. Rev. Mol. Cell Biol. 2019, 20, 509–510.
6. Deng, Z.B.; Poliakov, A.; Hardy, R.W.; Clements, R.; Liu, C.; Liu, Y.; Wang, J.; Xiang, X.; Zhang, S.; Zhuang, X.; et al. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 2009, 58, 2498–2505.
7. Thomou, T.; Mori, M.A.; Dreyfuss, J.M.; Konishi, M.; Sakaguchi, M.; Wolfrum, C.; Rao, T.N.; Winnay, J.N.; Garcia-Martin, R.; Grinspoon, S.K.; et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature 2017, 542, 450–455.
8. Kim, A.; Shah, A.S.; Nakamura, T. Extracellular Vesicles: A Potential Novel Regulator of Obesity and Its Associated Complications. Children 2018, 5, 152.
9. Scheja, L.; Heeren, J. The endocrine function of adipose tissues in health and cardiometabolic disease. Nat. Rev. Endocrinol. 2019, 15, 507–524.
10. White, U.; Elks, C.M.; Stephens, J.M. Adipose tissue: Physiology to metabolic dysfunction. In Endotext [Internet]; Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., Dungan, K., Grossman, A., Eds.; MDText.com: South Dartmouth, MA, USA, 2000.
11. Tchernof, A.; Despres, J.P. Pathophysiology of human visceral obesity: An update. Physiol. Rev. 2013, 93, 359–404.
12. Lorente-Cebrián, S.; González-Muniesa, P.; Milagro, F.I.; Martínez, J.A. MicroRNAs and other non-coding RNAs in adipose tissue and obesity: Emerging roles as biomarkers and therapeutic targets. Clin. Sci. 2019, 133, 23–40.
13. Gesta, S.; Tseng, Y.H.; Kahn, C.R. Developmental origin of fat: Tracking obesity to its source. Cell 2007, 131, 242–256.
14. Saltiel, A.R.; Olefsky, J.M. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Investig. 2017, 127, 1–4.
15. Petersen, M.C.; Shulman, G.I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 2018, 98, 2133–2223.
16. Bradford, S.T.; Nair, S.S.; Statham, A.L.; van Dijk, S.J.; Peters, T.J.; Anwar, F.; French, H.J.; von Martels, J.Z.H.; Sutcliffe, B.; Maddugoda, M.P.; et al. Methylome and transcriptome maps of human visceral and subcutaneous adipocytes reveal key epigenetic differences at developmental genes. Sci. Rep. 2019, 9, 9511.
17. Cannon, B.; Nedergaard, J. Brown adipose tissue: Function and physiological significance. Physiol. Rev. 2004, 84, 277–359.
18. Gilsanz, V.; Hu, H.H.; Kajimura, S. Relevance of brown adipose tissue in infancy and adolescence. Pediatr. Res. 2013, 73, 3–9.
19. Bartelt, A.; Heeren, J. Adipose tissue browning and metabolic health. Nat. Rev. Endocrinol. 2014, 10, 24–36.
20. Alcala, M.; Calderon-Dominguez, M.; Serra, D.; Herrero, L.; Viana, M. Mechanisms of impaired brown adipose tissue recruitment in obesity. Front Physiol. 2019, 10, 94.
21. Friedman, J. The long road to leptin. J. Clin. Investig. 2016, 126, 4727–4734.
22. Fietta, P. Focus on leptin, pleiotropic hormone. Minerva Med. 2005, 96, 65–75.
23. Sidhu, S.; Parikh, T.; Burman, K.D. Endocrine changes in obesity. In Endotext [Internet]; Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., Dungan, K., Grossman, A., Eds.; MDText.com: South Dartmouth, MA, USA, 2000.
24. Xiao, Y.; Liu, D.; Cline, M.A.; Gilbert, E.R. Chronic stress, epigenetics, and adipose tissue metabolism in the obese state. Nutr. Metab. 2020, 17, 88.
25. Konstantinides, S.; Schäfer, K.; Koschnick, S.; LoskutoV, D. Leptin dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J. Clin. Investig. 2001, 108, 1533–1540.
26. Yapijakis, C.; Kechagiadakis, M.; Nkenke, E.; Serefoglou, Z.; Avgoustidis, D.; Vylliotis, A.; Vairaktaris, E. Association of leptin—2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer. J. Cancer Res. Clin. Oncol. 2009, 135, 603–612.
27. Kita, S.; Maeda, N.; Shimomura, I. Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome. J. Clin. Investig. 2019, 129, 4041–4049.
28. Fang, H.; Judd, R.L. Adiponectin regulation and function. Compr. Physiol. 2018, 8, 1031–1063.
29. Maeda, N.; Shimomura, I.; Kishida, K.; Nishizawa, H.; Matsuda, M.; Nagaretani, H.; Furuyama, N.; Kondo, H.; Takahashi, M.; Arita, Y.; et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8, 731–737.
30. Kim, J.Y.; van de Wall, E.; Laplante, M.; Azzara, A.; Trujillo, M.E.; Hofmann, S.M.; Schraw, T.; Durand, J.L.; Li, H.; Li, G.; et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Investig. 2007, 117, 2621–2637.
31. Nagaraju, G.P.; Rajitha, B.; Aliya, S.; Kotipatruni, R.P.; Madanraj, A.S.; Hammond, A.; Park, D.; Chigurupati, S.; Alam, A.; Pattnaik, S. The role of adiponectin in obesity-associated female-specific carcinogenesis. Cytokine Growth Factor Rev. 2016, 31, 37–48.
32. Obata, Y.; Kita, S.; Koyama, Y.; Fukuda, S.; Takeda, H.; Takahashi, M.; Fujishima, Y.; Nagao, H.; Masuda, S.; Tanaka, Y.; et al. Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release. JCI Insight. 2018, 3, 99680.
33. Eguchi, A.; Lazic, M.; Armando, A.M.; Phillips, S.A.; Katebian, R.; Maraka, S.; Quehenberger, O.; Sears, D.D.; Feldstein, A.E. Circulating adipocyte-derived extracellular vesicles are novel markers of metabolic stress. J. Mol. Med. 2016, 94, 1241–1253.
34. Zhang, B.; Yang, Y.; Xiang, L.; Zhao, Z.; Ye, R. Adipose-derived exosomes: A novel adipokine in obesity-associated diabetes. J. Cell Physiol. 2019, 234, 16692–16702.
35. Crewe, C.; Joffin, N.; Rutkowski, J.M.; Kim, M.; Zhang, F.; Towler, D.A.; Gordillo, R.; Scherer, P.E. An endothelial-to-adipocyte extracellular vesicle axis governed by metabolic state. Cell 2018, 175, 695–708.e13.
36. Kranendonk, M.E.; Visseren, F.L.; van Balkom, B.W.; Nolte-’t Hoen, E.N.; van Herwaarden, J.A.; de Jager, W.; Schipper, H.S.; Brenkman, A.B.; Verhaar, M.C.; Wauben, M.H.; et al. Human adipocyte extracellular vesicles in reciprocal signaling between adipocytes and macrophages. Obesity 2014, 22, 1296–1308.
37. Ying, W.; Riopel, M.; Bandyopadhyay, G.; Dong, Y.; Birmingham, A.; Seo, J.B.; Ofrecio, J.M.; Wollam, J.; Hernandez-Carretero, A.; Fu, W.; et al. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell 2017, 171, 372–384.e12.
38. Zhao, H.; Shang, Q.; Pan, Z.; Bai, Y.; Li, Z.; Zhang, H.; Zhang, Q.; Guo, C.; Zhang, L.; Wang, Q. Exosomes From Adipose-Derived Stem Cells Attenuate Adipose Inflammation and Obesity Through Polarizing M2 Macrophages and Beiging in White Adipose Tissue. Diabetes 2018, 67, 235–247.
39. Ferrante, S.C.; Nadler, E.P.; Pillai, D.K.; Hubal, M.J.; Wang, Z.; Wang, J.M.; Gordish-Dressman, H.; Koeck, E.; Sevilla, S.; Wiles, A.A.; et al. Adipocyte-derived exosomal miRNAs: A novel mechanism for obesity-related disease. Pediatr. Res. 2015, 77, 447–454.
40. Ortega, F.J.; Mercader, J.M.; Catalán, V.; Moreno-Navarrete, J.M.; Pueyo, N.; Sabater, M.; Gómez-Ambrosi, J.; Anglada, R.; Fernández-Formoso, J.A.; Ricart, W.; et al. Targeting the circulating microRNA signature of obesity. Clin. Chem. 2013, 59, 781–792.
41. Markan, K.R.; Naber, M.C.; Ameka, M.K.; Anderegg, M.D.; Mangelsdorf, D.J.; Kliewer, S.A.; Mohammadi, M.; Potthoff, M.J. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes 2014, 63, 4057–4063.
42. Holmes, D. Adipose tissue: miR-92a hits the mark. Nat. Rev. Endocrinol. 2016, 12, 373.
43. Esau, C.; Kang, X.; Peralta, E.; Hanson, E.; Marcusson, E.G.; Ravichandran, L.V.; Sun, Y.; Koo, S.; Perera, R.J.; Jain, R.; et al. MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem. 2004, 279, 52361–52365.
44. Kim, Y.J.; Hwang, S.J.; Bae, Y.C.; Jung, J.S. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells. 2009, 27, 3093–3102.
45. Lee, E.K.; Lee, M.J.; Abdelmohsen, K.; Kim, W.; Kim, M.M.; Srikantan, S.; Martindale, J.L.; Hutchison, E.R.; Kim, H.H.; Marasa, B.S.; et al. miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol. Cell Biol. 2011, 31, 626–638.
46. Arner, P.; Kulyte, A. Microrna regulatory networks in human adipose tissue and obesity. Nat. Rev. Endocrinol. 2015, 11, 276–288.
47. Goody, D.; Pfeifer, A. Micrornas in brown and beige fat. Biochim. Biophys. Acta 2018, 1864, 29–36.
48. Alvarez-Dominguez, J.R.; Bai, Z.; Xu, D.; Yuan, B.; Lo, K.A.; Yoon, M.J.; Lim, Y.C.; Knoll, M.; Slavov, N.; Chen, S.; et al. De novo reconstruction of adipose tissue transcriptomes reveals long non-coding RNA regulators of brown adipocyte development. Cell Metab. 2015, 21, 764–776.
49. Zhao, X.Y.; Lin, J.D. Long Noncoding RNAs: A New Regulatory Code in Metabolic Control. Trends Biochem. Sci. 2015, 40, 586–596.
50. Sun, L.; Lin, J.D. Function and mechanism of long noncoding RNAs in adipocyte biology. Diabetes 2019, 68, 887–896.
51. Liu, S.; Sheng, L.; Miao, H.; Saunders, T.L.; MacDougald, O.A.; Koenig, R.J.; Xu, B. SRA gene knockout protects against diet-induced obesity and improves glucose tolerance. J. Biol. Chem. 2014, 289, 13000–13009.
52. Gernapudi, R.; Wolfson, B.; Zhang, Y.; Yao, Y.; Yang, P.; Asahara, H.; Zhou, Q. MicroRNA 140 promotes expression of long noncoding RNA NEAT1 in adipogenesis. Mol. Cell Biol. 2015, 36, 30–38.
53. Schmidt, E.; Dhaouadi, I.; Gaziano, I.; Oliverio, M.; Klemm, P.; Awazawa, M.; Mitterer, G.; Fernandez-Rebollo, E.; Pradas-Juni, M.; Wagner, W.; et al. LincRNA H19 protects from dietary obesity by constraining expression of monoallelic genes in brown fat. Nat. Commun. 2018, 9, 3622.
54. Woo, J.G.; Zhang, N.; Fenchel, M.; Jacobs, D.R., Jr.; Hu, T.; Urbina, E.M.; Burns, T.L.; Raitakari, O.; Steinberger, J.; Bazzano, L.; et al. Prediction of adult class II/III obesity from childhood BMI: The i3C consortium. Int. J. Obes. 2020, 44, 1164–1172.
55. Xekouki, P.; Nikolakopoulou, N.M.; Papageorgiou, A.; Livadas, S.; Voutetakis, A.; Magiakou, M.A.; Chrousos, G.P.; Spiliotis, B.E.; Dacou-Voutetakis, C. Glucose dysregulation in obese children: Predictive, risk, and potential protective factors. Obesity 2007, 15, 860–869.
56. Manios, Y.; Birbilis, M.; Moschonis, G.; Birbilis, G.; Mougios, V.; Lionis, C.; Chrousos, G.P. “Healthy Growth Study” group. Childhood Obesity Risk Evaluation based on perinatal factors and family sociodemographic characteristics: CORE index. Eur. J. Pediatr. 2013, 172, 551–555.
57. Tiosano, D.; Eisentein, I.; Militianu, D.; Chrousos, G.P.; Hochberg, Z. 11 beta-Hydroxysteroid dehydrogenase activity in hypothalamic obesity. J. Clin. Endocrinol. Metab. 2003, 88, 379–384.
58. Charmandari, E.; Chrousos, G.P. Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: Do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? Ann. N. Y. Acad. Sci. 2006, 1083, 37–53.
59. Stipancic, G. Secondary causes of obesity in children and adolescents. Cent. Eur. J. Paediatr. 2018, 14, 1–11.
60. Cummings, D.E.; Schwartz, M.W. Genetics and pathophysiology of human obesity. Annu. Rev. Med. 2003, 54, 453–471.
61. Salavoura, K.; Sofokleous, C.; Mavrou, A.; Kalaitzidaki, M.; Fryssira, H.; Kolialexi, A.; Yapijakis, C.; Zafiriou, D.; Metaxotou, C. Prader-Willi and Angelman syndrome in the Greek population: A clinical and molecular study. Balkan J. Med. Genet. 2003, 6, 21–32.
62. Farooqi, I.S.; O’Rahilly, S. Monogenic obesity in humans. Annu. Rev. Med. 2005, 56, 443–458.
63. Farooqi, I.S.; Keogh, J.M.; Yeo, G.S.H.; Lank, E.J.; Cheetham, T.; O’Rahilly, S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 2003, 348, 1085–1095.
64. Locke, A.E.; Kahali, B.; Berndt, S.I.; Justice, A.E.; Pers, T.H.; Day, F.R.; Powell, C.; Vedantam, S.; Buchkovich, M.L.; Yang, J.; et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015, 518, 197–206.
65. Kyrou, I.; Chrousos, G.P.; Tsigos, C. Stress, visceral obesity, and metabolic complications. Ann. N. Y. Acad. Sci. 2006, 1083, 77–110.
66. Pervanidou, P.; Chrousos, G.P. Stress and obesity/metabolic syndrome in childhood and adolescence. Int. J. Pediatr. Obes. 2011, 6, 21–28.
67. Izquierdo, A.G.; Crujeiras, A.B. Epigenetic biomarkers in metabolic syndrome and obesity. Prognostic Epigenetics 2019, 15, 269–287.
68. Obri, A.; Serra, D.; Herrero, L.; Mera, P. The role of epigenetics in the development of obesity. Biochem. Pharmacol. 2020, 177, 113973.
69. Fernandez-Twinn, D.S.; Hjort, L.; Novakovic, B.; Ozanne, S.E.; Saffery, R. Intrauterine programming of obesity and type 2 diabetes. Diabetologia 2019, 62, 1789–1801.
70. Li, C.J.; Fang, Q.H.; Liu, M.L.; Lin, J.N. Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cells/tissues. Theranostics 2020, 10, 7422–7435.
71. Ji, C.; Guo, X. The clinical potential of circulating microRNAs in obesity. Nat. Rev. Endocrinol. 2019, 15, 731–743.
72. Serino, M. Molecular paths linking metabolic diseases, gut microbiota dysbiosis and enterobacteria infections. J. Mol. Biol. 2018, 430, 581–590.
73. Oses, M.; Margareto Sanchez, J.; Portillo, M.P.; Aguilera, C.M.; Labayen, I. Circulating miRNAs as biomarkers of obesity and obesity-associated comorbidities in children and adolescents: A systematic review. Nutrients 2019, 11, 2890.
74. Prats-Puig, A.; Ortega, F.J.; Mercader, J.M.; Moreno-Navarrete, J.M.; Moreno, M.; Bonet, N.; Ricart, W.; Lopez-Bermejo, A.; Fernández-Real, J.M. Changes in Circulating MicroRNAs Are Associated with Childhood Obesity. J. Clin. Endocrinol. Metab. 2013, 98, E1655–E1660.
75. Masotti, A.; Baldassarre, A.; Fabrizi, M.; Olivero, G.; Loreti, M.C.; Giammaria, P.; Veronelli, P.; Graziani, M.P.; Manco, M. Oral glucose tolerance test unravels circulating miRNAs associated with insulin resistance in obese preschoolers. Pediatr. Obes. 2017, 12, 229–238.
76. Khalyfa, A.; Kheirandish-Gozal, L.; Bhattacharjee, R.; Khalyfa, A.A.; Gozal, D. Circulating microRNAs as potential biomarkers of endothelial dysfunction in obese children. Chest 2016, 149, 786–800.
77. Thompson, M.D.; Cismowski, M.J.; Serpico, M.; Pusateri, A.; Brigstock, D.R. Elevation of circulating microRNA levels in obese children compared to healthy controls. Clin. Obes. 2017, 7, 216–221.
78. Kang, M.; Liu, X.; Fu, Y.; Garvey, W.T. Improved systemic metabolism and adipocyte biology in miR-150 knockout mice. Metabolism 2018, 83, 139–148.
79. Dragomir, M.; Chen, B.; Calin, G.A. Exosomal lncRNAs as new players in cell-to-cell communication. Transl. Cancer Res. 2018, 7, S243–S252.
80. Patel, R.S.; Carter, G.; El Bassit, G.; Patel, A.A.; Cooper, D.R.; Murr, M.; Patel, N.A. Adipose-derived stem cells from lean and obese humans show depot specific differences in their stem cell markers, exosome contents and senescence: Role of protein kinase C delta (PKCδ) in adipose stem cell niche. Stem Cell Investig. 2016, 3, 2.
81. Sun, J.; Ruan, Y.; Wang, M.; Chen, R.; Yu, N.; Sun, L.; Liu, T.; Chen, H. Differentially expressed circulating LncRNAs and mRNA identified by microarray analysis in obese patients. Sci. Rep. 2016, 6, 35421.
82. Dallner, O.S.; Marinis, J.M.; Lu, Y.H.; Birsoy, K.; Werner, E.; Fayzikhodjaeva, G.; Dill, B.D.; Molina, H.; Moscati, A.; Kutalik, Z.; et al. Dysregulation of a long noncoding RNA reduces leptin leading to a leptin-responsive form of obesity. Nat. Med. 2019, 25, 507–516.
83. Kilpelainen, T.O.; Carli, J.F.; Skowronski, A.A.; Sun, Q.; Kriebel, J.; Feitosa, M.F.; Hedman, Å.K.; Drong, A.W.; Hayes, J.E.; Zhao, J.; et al. Genome-wide meta-analysis uncovers novel loci infuencing circulating leptin levels. Nat. Commun. 2016, 7, 10494.
84. Lo, K.A.; Huang, S.; Walet, A.C.E.; Zhang, Z.C.; Leow, M.K.S.; Liu, M.; Sun, L. Adipocyte long-noncoding RNA transcriptome analysis of obese mice identified Lnc-leptin, which regulates leptin. Diabetes 2018, 67, 1045–1056.
85. Wheeler, E.; Huang, N.; Bochukova, E.G.; Keogh, J.M.; Lindsay, S.; Garg, S.; Henning, E.; Blackburn, H.; Loos, R.J.; Wareham, N.J.; et al. Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity. Nat. Genet. 2013, 45, 513–517.
86. Liu, Y.; Ji, Y.; Li, M.; Wang, M.; Yi, X.; Yin, C.; Wang, S.; Zhang, M.; Zhao, Z.; Xiao, Y. Integrated analysis of long noncoding RNA and mRNA expression profile in children with obesity by microarray analysis. Sci. Rep. 2018, 8, 8750.
87. Chen, R.; Xin, G.; Zhang, X. Long non-coding RNA HCP5 serves as a ceRNA sponging miR-17-5p and miR-27a/b to regulate the pathogenesis of childhood obesity via the MAPK signaling pathway. J. Pediatr. Endocrinol. Metab. 2019, 32, 1327–1339.
88. Zhang, Y.; Liu, Y.; Liu, H.; Tang, W.H. Exosomes: Biogenesis, biologic function and clinical potential. Cell Biosci. 2019, 9, 19.
89. Kong, Q.; Guo, X.; Guo, Z.; Su, T. Urinary Exosome miR-424 and miR-218 as Biomarkers for Type 1 Diabetes in Children. Clin. Lab. 2019, 65.
90. Vlachakis, D.; Mitsis, Τ.; Nicolaides, N.; Efthimiadou, A.; Giannakakis, A.; Bacopoulou, F.; Chrousos, G.P. Functions, pathophysiology and current insights of exosomal endocrinology. Mol. Med. Rep. 2020, 23, 26.
91. Brandt, S.; Roos, J.; Inzaghi, E.; Kotnik, P.; Kovac, J.; Battelino, T.; Cianfarani, S.; Nobili, V.; Colajacomo, M.; Kratzer, W.; et al. Circulating levels of miR-122 and nonalcoholic fatty liver disease in pre-pubertal obese children. Pediatr. Obes. 2018, 13, 175–182.
92. Wei, S.; Du, M.; Jiang, Z.; Hausman, G.J.; Zhang, L.; Dodson, M.V. Long noncoding RNAs in regulating adipogenesis: New RNAs shed lights on obesity. Cell. Mol. Life Sci. 2016, 73, 2079–2087.
93. Conlan, R.S.; Pisano, S.; Oliveira, M.I.; Ferrari, M.; Mendes Pinto, I. Exosomes as Reconfigurable Therapeutic Systems. Trends Mol. Med. 2017, 23, 636–650.
94. Pang, H.; Luo, S.; Xiao, Y.; Xia, Y.; Li, X.; Huang, G.; Xie, Z.; Zhou, Z. Emerging Roles of Exosomes in T1DM. Front Immunol. 2020, 11, 593348.
95. Liu, C.; Su, C. Design strategies and application progress of therapeutic exosomes. Theranostics 2019, 9, 1015–1028.
96. Yapijakis, C. Regulatory Role of MicroRNAs in Brain Development and Function. Adv. Exp. Med. Biol. 2020, 1195, 237–247.
97. Pascut, D.; Tamini, S.; Bresolin, S.; Giraudi, P.; Basso, G.; Minocci, A.; Tiribelli, C.; Grugni, G.; Sartorio, A. Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity. Endocr. Connect. 2018, 7, 1262–1274.
98. Marcet, B.; Barbry, P.; Waldmann, R.; Mari, B.; Coraux, C. Use of MicroRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. U.S. Patent 9,023,821, 5 May 2015.